Botucatu, S%C3%A3O%20PAULO1 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Botucatu, S%C3%A3O%20PAULO

Find 1 actively recruiting myalgic encephalomyelitis clinical trials in Botucatu, S%C3%A3O%20PAULO. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
225
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Botucatu

About Myalgic Encephalomyelitis Clinical Trials in Botucatu

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 1 myalgic encephalomyelitis clinical trials recruiting participants in Botucatu, S%C3%A3O%20PAULO. These studies are seeking a combined 225 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Botucatu — FAQ

Are there myalgic encephalomyelitis clinical trials in Botucatu?

Yes, there are 1 myalgic encephalomyelitis clinical trials currently recruiting in Botucatu, S%C3%A3O%20PAULO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Botucatu?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Botucatu research site will contact you about next steps.

Are clinical trials in Botucatu free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Botucatu studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 1 active trials in Botucatu are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated March 2, 2026 from ClinicalTrials.gov